"Understanding the Patient Experience of Stage 3 Unresectable Non-Small Cell Lung Cancer (NSCLC) in the Immuno-oncology Era"

Research Grant

Duke Scholars

Principal Investigator Thomas William LeBlanc Medicine, Hematologic Malignancies and Cellular Therapy

Co Investigator Jeffrey Melson Clarke Medicine, Medical Oncology

Statistician Steven Wolf

Awarded By

AstraZeneca PLC

Start Date

December 10, 2020

End Date

May 13, 2022

Awarded By

AstraZeneca PLC

Start Date

December 10, 2020

End Date

May 13, 2022